Magdalena R. F.
- Country
- Poland
- Department
- N/A
Research Overview
- An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis
- Evaluation of Long-term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Patients with Moderate-to-Severe Plaque Psoriasis
- Phase 3 Randomized Double-Blind Study on Efficacy and Safety of Subcutaneous Tildrakizumab in Moderate to Severe Genital Psoriasis
Data & Insights
Has run more than one trial at 64 of 225 partner sites.
Specializations
Dermatological Conditions
Specializes in treating various manifestations of psoriasis, with particular emphasis on moderate to severe cases affecting different body areas.
- Plaque Psoriasis Management
- Genital Psoriasis Treatment
- Long-term Disease Control
Focuses on innovative therapeutic approaches for managing chronic dermatological conditions.
Treatment Modalities
Investigates various administration routes for systemic therapies, including oral medications and subcutaneous treatments for dermatological conditions.
- Oral Therapeutic Agents
- Subcutaneous Treatments
- Daily Administration Protocols
Explores both established and emerging treatment delivery methods for optimal patient outcomes.
Clinical Assessment
Employs specialized evaluation methods including Physician's Global Assessment tools for monitoring treatment efficacy in dermatological conditions.
- Disease Severity Assessment
- Treatment Response Monitoring
- Long-term Safety Evaluation
Utilizes comprehensive assessment approaches to track therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.